Cemex (NYSE:CX) Stock

CEMEX SAB-SPONS ADR PART CER

Cemex

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.

Cemex SAB de CV

C5 ACQUISITION CORP L A

CXApp Inc

CALIBRE MINING CORP ORD by Calibre Mining Corp.

Calibre Mining Corp

CORIX BIOSCIENCE INC by Corix Bioscience, Inc.

Corix Bioscience Inc

Cardxx Inc

CYPHER METAVERSE INC by CYPHER METAVERSE INC.

Cypher Metaverse Inc

Crexendo Inc

MFS High Income Municipal Trust Common Stock

Mfs High Income Municipal Trust

COMPUTER & TECHS HLDGS by Computer & Technologies Holdings Ltd.

Computer And Technologies Holdings Ltd

MFS Investment Grade Municipal Trust Common Stock

Mfs Investment Grade Municipal Trust

COMMODORE APPLIED TECHS by Commodore Applied Technologies, Inc.

CHINA XLX FERTILISER LTD by China XLX Fertiliser Ltd.

Sprinklr Inc

CargoX

Core Lithium Ltd

CHINA RES MIXC LIFESTYLE by CHINA RES MIXC LIFESTYLE SVCS LTD.

Listed Funds Trust Teucrium 2x Daily Corn ETF

WisdomTree China ex-State-Owned Enterprises Fund

Crane NXT Co

Covalent X Token - United States Dollar

CoreCivic Inc

C21 INVESTMENTS INC ORD by C21 Investments Inc.

C21 Investments Inc

CMX GOLD & SILVER CRP ORD by CMX Gold & Silver Corp

CMX Gold & Silver Corp

Ratings for Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $6.41, a high estimate of $9.00, and a low estimate of $5.00. This current average has increased by 6.83% from the previous average price target of $6.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1745953280_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of Cemex among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anthony Codling</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Underperform</td>
<td>$5.25</td>
<td>$5.00</td>
</tr>
<tr>
<td>Adrian Huerta</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$6.80</td>
<td>$6.00</td>
</tr>
<tr>
<td>Anthony Codling</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$5.00</td>
<td>$6.00</td>
</tr>
<tr>
<td>Bruno Amorim</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$9.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Anthony Codling</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Underperform</td>
<td>$6.00</td>
<td>$5.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cemex. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Cemex compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Cemex's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Cemex's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Cemex analyst ratings.</a>
<h2>All You Need to Know About Cemex</h2>
Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services.
<h3>Cemex's Financial Performance</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Cemex's revenue growth over a period of 3M has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately -6.8%. This indicates a decrease in the company's top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Cemex's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 1.27%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Cemex's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 0.4%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Cemex's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.17%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Cemex's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.6, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Beyond The Numbers: 5 Analysts Discuss Cemex Stock

RBC Capital analyst Anthony Codling maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Underperform and raises the price target from $5 to $5.25.

News

Price Target

RBC Capital Maintains Underperform on Cemex, Raises Price Target to $5.25

JP Morgan analyst Adrian Huerta maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Neutral and raises the price target from $6 to $6.8.

JP Morgan Maintains Neutral on Cemex, Raises Price Target to $6.8

U.S. stocks were mostly higher, with the Dow Jones index gaining around 200 points on Monday.
Shares of CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) rose sharply during Monday's session following <a href="https://www.benzinga.com/25/04/45038161/cemexs-q1-results-show-strong-emea-growth-offset-by-mexican-market-struggles">first-quarter results</a>.
The company reported first-quarter net sales of $3.65 million, missing the consensus of $3.80 billion. Net sales fell 7% year over year (Y/Y), mainly due to lower volumes in Mexico. EBITDA declined 18% Y/Y to $601 million in the quarter, with a margin contracted 2.0ppt Y/Y to 16.5% in the quarter.
Cemex expects recurrent yearly EBITDA savings of at least $150 million in 2025 and $350 million by 2027.
Cemex shares jumped 4.2% to $6.16 on Monday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Plug Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) shares jumped 39.4% to $1.13 after the company signed a secured credit facility with Yorkville Advisors. The company also reported preliminary first-quarter results.</li>
<li>CG Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGON#NASDAQ">CGON</a>) surged 30% to $29.02 after the company announced that cretostimogene grenadenorepvec monotherapy data was presented at the American Urological Association Annual Meeting.</li>
<li>Wolfspeed, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) rose 24.5% to $4.07.</li>
<li>Sabre Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABR#NASDAQ">SABR</a>) gained 20.3% to $2.6350 as the company entered into definitive agreement to sell its Hospitality Solutions business unit to TPG for $1.1 billion.</li>
<li>Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) rose 17.4% to $8.23.</li>
<li>TMC the metals company Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) gained 15.9% to $3.5350.</li>
<li>Rapport Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPP#NASDAQ">RAPP</a>) climbed 12.6% to $11.96.</li>
<li>VEON Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEON#NASDAQ">VEON</a>) gained 12.2% to $47.83.</li>
<li>ADMA Biologics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) rose 12% to $24.49 as the company announced the FDA approval of its yield enhancement production process.</li>
<li>Summit Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) gained 10% to $25.79.</li>
<li>UroGen Pharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) gained 10% to $10.85 after the company highlighted nearly four-year duration of response in OLYMPUS long-term follow-up study of JELMYTO.</li>
<li>Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) rose 7.6% to $7.41.</li>
<li>Hims &amp; Hers Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) gained 6.1% to $29.82.</li>
<li>Peloton Interactive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTON#NASDAQ">PTON</a>) rose 5.4% to $6.63. Truist Securities analyst Youssef Squali upgraded Peloton Interactive from Hold to Buy.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45038052/top-2-industrials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Industrials Stocks That May Fall Off A Cliff This Quarter</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

Movers

Trading Ideas

ADMA

CGON

Hims & Hers Health, Inc. Class A Common Stock

HIMS

PLUG

PONY

PTON

RAPP

SABR

SMMT

URGN

VEON

WOLF

Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday

Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) shares are trading higher premarket on Monday. The company reported first-quarter net sales of $3.65 million, missing the consensus of $3.80 billion.
Net sales <a target="_blank" href="https://www.cemex.com/w/cemex-reports-record-first-quarter-net-income-new-ceo-with-strong-commitment-to-bolster-shareholder-return" rel="noreferrer noopener">fell </a>7% year over year (Y/Y), mainly due to lower volumes in Mexico.
Mexico sales declined 25% Y/Y to $981 million, United States sales fell 4% Y/Y to $1.19 billion, Europe, Middle East, and Africa rose 2% Y/Y to $1.07 billion, and South, Central America, and the Caribbean increased 2% Y/Y to $314 million.
EBITDA declined 18% Y/Y to $601 million in the quarter, with a margin contracted 2.0ppt Y/Y to 16.5% in the quarter.
Lower volumes and weather-related maintenance activity impacted the EBITDA margin.
Segment-wise, operating EBITDA fell 27% Y/Y in Mexico, 20% Y/Y in the United States and 3% Y/Y in South and Central America and the Caribbean, while it increased 40% Y/Y in Europe, the Middle East and Africa segment.
Outlook: Cemex expects recurrent yearly EBITDA savings of at least $150 million in<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener"> 2025 and $350 million by 2027</a>.
Given the macroeconomic uncertainties and anticipated savings from Project Cutting Edge, the company continues to forecast flat EBITDA performance <a href="https://www.cemex.com/documents/d/cemex/1q25-presentation-english" target="_blank" rel="noreferrer noopener">for </a>2025.
Cemex remained optimistic about volume growth in EMEA and SCAC, anticipates improved performance in Mexico, and expects stable market conditions in the U.S. during the second half of 2025.
The company projects FCF to deliver $500 million in savings in 2025.
Price Action: CX shares are up 2.53% at $6.070&nbsp;premarket at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/45029247/unitedhealth-t-mobile-and-fiserv-are-among-top-12-large-cap-losers-last-week-apr-21-apr-25-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">UnitedHealth, T-Mobile And Fiserv Are Among Top 12 Large-Cap Losers Last Week (Apr 21-Apr 25): Are The Others In Your Portfolio?</a></li>
</ul>

Equities

Mid Cap

Guidance

Cemex's Q1 Results Show Strong EMEA Growth, Offset by Mexican Market Struggles

Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) reported quarterly earnings of $0.08 per share which missed the analyst consensus estimate of $0.10 by 20 percent. This is a 50 percent decrease over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $3.65 billion which missed the analyst consensus estimate of $3.80 billion by 4.08 percent. This is a 7.43 percent decrease over sales of $3.94 billion the same period last year.

Earnings

Earnings Misses

Cemex Q1 GAAP EPS $0.08 Misses $0.10 Estimate, Sales $3.65B Miss $3.80B Estimate

<h3>Companies Reporting Before The Bell</h3>
• Guardforce AI Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFAI#NASDAQ">GFAI</a>) is projected to report earnings for its Fiscal Year 2024. 
• Bright Scholar Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEDU#NYSE">BEDU</a>) is expected to report earnings for its second quarter. 
• Kandi Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNDI#NASDAQ">KNDI</a>) is estimated to report earnings for its fourth quarter. 
• SuperCom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPCB#NASDAQ">SPCB</a>) is projected to report quarterly loss at $0.46 per share on revenue of $6.48 million. 
• Provident Finl Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROV#NASDAQ">PROV</a>) is expected to report quarterly earnings at $0.24 per share on revenue of $9.86 million. 
• Toyo Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOYO#NASDAQ">TOYO</a>) is estimated to report earnings for its Fiscal Year 2024. 
• InMode (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INMD#NASDAQ">INMD</a>) is projected to report quarterly earnings at $0.35 per share on revenue of $77.57 million. 
• BankUnited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKU#NYSE">BKU</a>) is likely to report quarterly earnings at $0.76 per share on revenue of $263.57 million. 
• Alliance Res Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARLP#NASDAQ">ARLP</a>) is projected to report quarterly earnings at $0.51 per share on revenue of $556.31 million. 
• Roper Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROP#NASDAQ">ROP</a>) is projected to report quarterly earnings at $4.75 per share on revenue of $1.89 billion. 
• Revvity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVTY#NYSE">RVTY</a>) is estimated to report quarterly earnings at $0.96 per share on revenue of $662.30 million. 
• Opera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRA#NASDAQ">OPRA</a>) is expected to report quarterly earnings at $0.24 per share on revenue of $132.48 million. 
• Silicom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILC#NASDAQ">SILC</a>) is likely to report quarterly loss at $0.37 per share on revenue of $14.37 million. 
• Rithm Property Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPT#NYSE">RPT</a>) is projected to report earnings for its first quarter. 
• Fomento Economico (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMX#NYSE">FMX</a>) is estimated to report earnings for its first quarter. 
• Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) is likely to report quarterly earnings at $4.04 per share on revenue of $1.12 billion. 
• Perfect (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PERF#NYSE">PERF</a>) is estimated to report quarterly earnings at $0.02 per share on revenue of $16.16 million. 
• Bank of Marin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRC#NASDAQ">BMRC</a>) is likely to report quarterly earnings at $0.31 per share on revenue of $27.99 million. 
• Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $3.85 billion. 
<h3>Companies Reporting After The Bell</h3>
• Merchants Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIN#NASDAQ">MBIN</a>) is expected to report quarterly earnings at $1.28 per share on revenue of $169.00 million. 
• Medifast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) is projected to report quarterly loss at $0.25 per share on revenue of $116.40 million. 
• SunCar Tech Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDA#NASDAQ">SDA</a>) is projected to report earnings for its Fiscal Year 2024. 
• EZCORP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZPW#NASDAQ">EZPW</a>) is expected to report quarterly earnings at $0.30 per share on revenue of $306.17 million. 
• Beyond (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYON#NYSE">BYON</a>) is projected to report quarterly loss at $0.63 per share on revenue of $288.13 million. 
• Sanmina (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANM#NASDAQ">SANM</a>) is likely to report quarterly earnings at $1.38 per share on revenue of $1.97 billion. 
• Firstsun Capital Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSUN#NASDAQ">FSUN</a>) is expected to report earnings for its first quarter. 
• CVR Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVI#NYSE">CVI</a>) is estimated to report quarterly loss at $0.75 per share on revenue of $1.65 billion. 
• Leggett &amp; Platt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEG#NYSE">LEG</a>) is projected to report quarterly earnings at $0.22 per share on revenue of $1.02 billion. 
• Welltower (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) is estimated to report quarterly earnings at $1.14 per share on revenue of $2.37 billion. 
• Harmonic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $127.51 million. 
• Financial Institutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FISI#NASDAQ">FISI</a>) is likely to report quarterly earnings at $0.80 per share on revenue of $56.32 million. 
• Waste Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) is likely to report quarterly earnings at $1.68 per share on revenue of $6.12 billion. 
• Brixmor Property Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRX#NYSE">BRX</a>) is estimated to report earnings for its first quarter. 
• Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) is expected to report quarterly earnings at $1.30 per share on revenue of $546.93 million. 
• Ameris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABCB#NYSE">ABCB</a>) is estimated to report quarterly earnings at $1.14 per share on revenue of $276.83 million. 
• Rambus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) is expected to report quarterly earnings at $0.50 per share on revenue of $162.83 million. 
• PotlatchDeltic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCH#NASDAQ">PCH</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $243.68 million. 
• Cincinnati Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CINF#NASDAQ">CINF</a>) is likely to report quarterly loss at $0.52 per share on revenue of $2.71 billion. 
• F5 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) is projected to report quarterly earnings at $3.22 per share on revenue of $703.63 million. 
• NXP Semiconductors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>) is expected to report quarterly earnings at $2.60 per share on revenue of $2.83 billion. 
• Cadence Design Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) is estimated to report quarterly earnings at $1.50 per share on revenue of $1.24 billion. 
• Gerdau (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GGB#NYSE">GGB</a>) is estimated to report earnings for its first quarter. 
• Alexandria Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) is expected to report quarterly earnings at $2.29 per share on revenue of $758.46 million. 
• Nucor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) is projected to report quarterly earnings at $0.56 per share on revenue of $7.31 billion. 
• Brown &amp; Brown (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) is expected to report quarterly earnings at $1.28 per share on revenue of $1.41 billion. 
• SJW Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SJW#NASDAQ">SJW</a>) is projected to report quarterly earnings at $0.37 per share on revenue of $160.54 million. 
• Two Harbors Inv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWO#NYSE">TWO</a>) is likely to report quarterly earnings at $0.42 per share on revenue of $-28 million. 
• Five Star (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSBC#NASDAQ">FSBC</a>) is projected to report quarterly earnings at $0.58 per share on revenue of $34.94 million. 
• Seven Hills Realty Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEVN#NASDAQ">SEVN</a>) is likely to report quarterly earnings at $0.31 per share on revenue of $7.58 million. 
• Solaris Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEI#NYSE">SEI</a>) is projected to report quarterly earnings at $0.13 per share on revenue of $119.20 million. 
• SBA Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>) is expected to report quarterly earnings at $2.32 per share on revenue of $661.98 million. 
• CVR Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAN#NYSE">UAN</a>) is expected to report earnings for its first quarter. 
• CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) is likely to report quarterly earnings at $0.80 per share on revenue of $975.80 million. 
• UFP Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UFPI#NASDAQ">UFPI</a>) is projected to report quarterly earnings at $1.57 per share on revenue of $1.61 billion. 
• Woodward (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) is projected to report quarterly earnings at $1.46 per share on revenue of $838.72 million. 
• Simpson Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSD#NYSE">SSD</a>) is projected to report quarterly earnings at $1.77 per share on revenue of $544.94 million. 
• Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) is projected to report quarterly earnings at $0.61 per share on revenue of $680.54 million. 
• Transocean (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) is projected to report quarterly loss at $0.10 per share on revenue of $884.92 million. 
• Piedmont Office Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PDM#NYSE">PDM</a>) is projected to report quarterly earnings at $0.35 per share on revenue of $141.29 million. 
• Kforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFRC#NYSE">KFRC</a>) is estimated to report quarterly earnings at $0.47 per share on revenue of $334.61 million. 
• Universal Health Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) is expected to report quarterly earnings at $4.38 per share on revenue of $4.16 billion. 
• COPT Defense Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDP#NYSE">CDP</a>) is likely to report quarterly earnings at $0.65 per share on revenue of $185.78 million. 
• Crown Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>) is projected to report quarterly earnings at $1.23 per share on revenue of $2.82 billion. 
• Noble Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NE#NYSE">NE</a>) is likely to report quarterly earnings at $0.36 per share on revenue of $863.31 million. 
• Amkor Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) is estimated to report quarterly earnings at $0.09 per share on revenue of $1.28 billion. 
• NOV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOV#NYSE">NOV</a>) is estimated to report quarterly earnings at $0.26 per share on revenue of $2.10 billion. 
• Northwest Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWBI#NASDAQ">NWBI</a>) is estimated to report quarterly earnings at $0.24 per share on revenue of $142.16 million. 
• RBB Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBB#NASDAQ">RBB</a>) is likely to report quarterly earnings at $0.38 per share on revenue of $28.98 million. 
• Franklin BSP Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBRT#NYSE">FBRT</a>) is expected to report quarterly earnings at $0.37 per share on revenue of $53.04 million. 
• Netstreit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTST#NYSE">NTST</a>) is expected to report quarterly earnings at $0.31 per share on revenue of $44.21 million. 
• Enterprise Finl Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EFSC#NASDAQ">EFSC</a>) is likely to report earnings for its first quarter. 
• Alerus Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALRS#NASDAQ">ALRS</a>) is estimated to report quarterly earnings at $0.44 per share on revenue of $66.19 million. 
• Ultra Clean Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) is likely to report quarterly earnings at $0.31 per share on revenue of $561.40 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABCB

ALRS

AMKR

ARLP

BEDU

BMRC

BYON

CDNS

CINF

EFSC

EZPW

FBRT

FFIV

FISI

Fomento Economico Mexicano S.A.B. De C.V.

FSBC

FSUN

GFAI

HLIT

INMD

KFRC

KNDI

MBIN

NTST

NWBI

NXPI

OPRA

PERF

PROV

RMBS

RVTY

SANM

SBAC

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SEVN

SILC

SPCB

TOYO

UCTT

UFPI

WELL

Earnings Scheduled For April 28, 2025

Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) is gearing up to announce its quarterly earnings on Monday, 2025-04-28. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Cemex will report an earnings per share (EPS) of $0.00.
The announcement from Cemex is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Here's a look at Cemex's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td></td>
<td>0.18</td>
<td>0.22</td>
<td>0.12</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.16</td>
<td>0.14</td>
<td>0.17</td>
<td>0.17</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>-4.0%</td>
<td>1.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<h3>Cemex Share Price Analysis</h3>
Shares of Cemex were trading at $5.69 as of April 24. Over the last 52-week period, shares are down 29.53%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/CX/earnings">To track all earnings releases for Cemex visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview: Cemex

RBC Capital analyst Anthony Codling maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Underperform and lowers the price target from $6 to $5.

RBC Capital Maintains Underperform on Cemex, Lowers Price Target to $5

Goldman Sachs analyst Bruno Amorim maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Buy and raises the price target from $8 to $9.

Goldman Sachs Maintains Buy on Cemex, Raises Price Target to $9

Asset Sales

Mexico's Cemex Is Reportedly Exploring A Sale Of Its Columbian Unit

RBC Capital analyst Anthony Codling maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Underperform and raises the price target from $5 to $6.

RBC Capital Maintains Underperform on Cemex, Raises Price Target to $6

Management

Cemex CEO Fernando González Decides To Retire; Jaime Muguiro Appointed As New CEO, Effective April 1, 2025

WIIM

Cemex shares are trading higher after the company reported better-than-expected Q4 EPS results.

Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.04 by 300 percent. This is a 153.33 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $3.811 billion which missed the analyst consensus estimate of $3.894 billion by 2.14 percent. This is a 89.72K percent increase over sales of $4.243 million the same period last year.

Earnings Beats

Cemex Q4 2024 GAAP EPS $0.16 Beats $0.04 Estimate, Sales $3.811B Miss $3.894B Estimate

AAMI

AFRM

AGCO

AMRK

AMZN

APTV

BILL

CCEC

CIGI

CLFD

CLSK

CRNC

CTLP

DOCS

EMBC

ENTG

EXPE

EXPO

FARM

FBIN

FTNT

GOOS

GPRO

GTES

GTIM

HUBG

IBEX

IDCC

IIIV

ILMN

INTR

KVUE

LADR

LESL

Laboratory Corporation Of America Holdings

LION

LITE

LIVE

LQDT

LSPD

LTRX

MAGN

MATW

MCFT

MCHP

MKTX

MPWR

MSGE

MTSI

Earnings Scheduled For February 6, 2025

RBC Capital analyst Anthony Codling downgrades Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) from Sector Perform to Underperform and lowers the price target from $6 to $5.

Downgrades

RBC Capital Downgrades Cemex to Underperform, Lowers Price Target to $5

Scotiabank analyst Francisco Suarez maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Sector Outperform and lowers the price target from $8.9 to $8.2.

Scotiabank Maintains Sector Outperform on Cemex, Lowers Price Target to $8.2

Scotiabank analyst Francisco Suarez maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Sector Outperform and lowers the price target from $10 to $8.9.

Scotiabank Maintains Sector Outperform on Cemex, Lowers Price Target to $8.9

RBC Capital analyst Anthony Codling maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Sector Perform and lowers the price target from $6.5 to $6.

RBC Capital Maintains Sector Perform on Cemex, Lowers Price Target to $6

Press Releases

Fortune Recognizes Cemex for the Fourth Time as a Company That Is Changing the World

EU Backs Pioneering CO2 Capture Project at Cemex's Rüdersdorf Cement Plant

Cemex Recognized at COP29 for Solar Clinker Breakthrough

Cemex Announces CEO Transition

Cemex Announces Senior Level Organizational Changes

Cemex celebrates 25 years of biodiversity conservation and restoration at El Carmen Nature Reserve

Cemex Recognized as One of the World's Most Ethical Companies®

Cemex showcases significant operational and sustainability advancements in its 2024 Integrated Report

Comments

Cemex

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL